Showing results (21-30 of 188) with videos related to
Sort By:
Pageof 19
Cancer Treatment Reports|October 1, 1987
Limited sampling model for vinblastine pharmacokineticsM J Ratain, N J VogelzangInvestigational New Drugs|June 1, 2000
Development of target-based antineoplastic agentsW M Stadler, M J RatainClinical Pharmacology and Therapeutics|August 31, 2007
Rapamycin: something old, something new, sometimes borrowed and now renewedC M Hartford, M J RatainCancer Research|September 1, 1986
Phase I and pharmacological study of vinblastine by prolonged continuous infusionM J Ratain, N J VogelzangJournal of the National Cancer Institute|September 5, 1990
Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administrationR L Schilsky, M J RatainClinical Pharmacology and Therapeutics|August 22, 2013
Are drug labels static or dynamic?M J Seminerio, M J RatainClinical Pharmacology and Therapeutics|January 20, 2009
Biomarkers in early cancer drug development: limited utilityR H Glassman, M J RatainClinical Pharmacokinetics|December 7, 2000
Pharmacogenetics: a tool for individualizing antineoplastic therapyF Innocenti, L Iyer, M J RatainAnnual Review of Medicine|January 15, 2003
Pharmacogenetics in cancer treatmentR Nagasubramanian, F Innocenti, M J RatainDrug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecanF Innocenti, L Iyer, M J RatainPageof 19